SEC Form 4 · accession 0000874015-17-000024
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley T Crooke
Officer — Chairman and CEO · Director
Period of report
Mar 2, 2017
Accepted (ET)
Mar 6, 2017 · 7:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2017 | M | 11,000 | $7.25 | A | 49,014 | D | |
| Common StockF1 | Mar 2, 2017 | S | 11,000 | $51.05 | D | 38,014 | D | |
| Common StockF2 | Mar 2, 2017 | M | 1,100 | $10.29 | A | 4,162 | I | By wife |
| Common StockF2 | Mar 2, 2017 | S | 1,100 | $51.05 | D | 3,062 | I | By wife |
| Common Stock | holding | — | — | — | 725,391 | I | By trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $7.25 | Mar 2, 2017 | M | 11,000 | D | Jan 3, 2016 | Jan 2, 2019 | Common Stock | 11,000 | 53,462 | D |
| Employee Stock Option (right to buy) | $10.29 | Mar 2, 2017 | M | 1,100 | D | Jan 3, 2015 | Jan 2, 2018 | Common Stock | 1,100 | 1,500 | I |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 9/21/2015.
- F2Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person's wife on 9/21/2015.